-
Need a Ride?Cancer center expands pilot program to provide transportation for patients to get to appointments.
by Karen Blum
-
February 4: The Week in Cancer NewsCAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.
by Eric Fitzsimmons
-
January 28: The Week in Cancer NewsPharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.
by Marci A. Landsmann
-
January 21: The Week in Cancer NewsMetastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
by Kevin McLaughlin
-
January 14: The Week in Cancer NewsCancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.
by Eric Fitzsimmons
-
Cancer, On and Off StageErin Cronican, who has stage IV breast cancer, plays the lead role of a professor diagnosed with metastatic ovarian cancer in the New York City production of Wit.
by Pamela Rafalow Grossman
-
January 7: The Week in Cancer NewsThree out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.
by Marci A. Landsmann
-
Acknowledging the Stress of CancerA patient advocate session at the San Antonio Breast Cancer Symposium offered practical tips for dealing with cancer.
by Marci A. Landsmann
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
